Facilitating cartilage regeneration by heterogeneous progenitor cells
Facilitating cartilage regeneration by heterogeneous progenitor cells
批准号:
8333207
负责人:
Ryan Michael Porter
金额:
$24.7万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2014-08-31
关键词:
AffectAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryArthritisArticular Range of MotionBiologicalCaringCartilageCartilage injuryCellsChondrogenesisClinicalComplexDefectDegenerative polyarthritisDepositionDevelopmentEnvironmentGoalsHealedHumanImmunocompromised HostIn SituIncidenceInflammationInflammatoryInstructionInterleukin-1JointsLeadMediatingMentorsMesenchymal Stem CellsModelingMonitorMusculoskeletalNatural regenerationOperative Surgical ProceduresOryctolagus cuniculusOutcomePainPathogenesisPhasePlayPopulationProcessProliferatingQuality of lifeRattusRegenerative MedicineReporterRoleSecondary toShapesSignal TransductionSiteStem cellsSurgical InjuriesTNF geneTimeTissue EngineeringTraining SupportTransplantationTraumaTumor Necrosis Factor-alphaWorkarticular cartilagebasecartilage regenerationcartilage repairclinical applicationcytokinehealingimprovedin vivoinjuredinjury and repairinterestjoint injuryosteochondral tissuepost-doctoral trainingregenerativerepairedsuccesstissue regenerationtool
中文摘要
目前软骨损伤的护理标准不能可靠地提供持续的临床改善,因此
人们对开发替代的生物修复/再生方法很感兴趣。
再生医学方法通常涉及招募或移植内源性
间充质祖细胞(MFC)移植到缺损处。在受控条件下,这些细胞具有
有可能沿着相关的肌肉骨骼谱系增殖、分化和再生受损的骨骼
组织基质。然而,关节内环境可能不利于软骨形成;具体地说,
损伤关节内的炎症会抑制组织再生。局部的关节炎症是由
白介素1和肿瘤坏死因子-a等细胞因子。尽管促炎性细胞因子在
在骨性关节炎的发病机制中起重要作用,但对它们如何影响软骨修复知之甚少。
涉及跨国公司的战略。塑造这个项目的中心假设是炎症继发于关节
创伤或随后的手术干预会抑制软骨内MFC的再生活性。
缺陷,因此限制了修复。在指导阶段,为以下对象开发了报告器构造工具集
监测人类MFC分化的状态,使用这些结构非侵入性地跟踪
免疫受损的大鼠软骨损伤模型中的炎症和软骨形成活性。vt.在.的基础上
过渡到项目的独立阶段,在指导阶段开发的工具将有所帮助
描述手术引起的关节创伤所致的促炎环境,确定
影响软骨形成和缺陷修复的因素。既有免疫能力也有无免疫能力
关节损伤的动物模型将被用来确定MFC修复/再生软骨的能力
不受已确定因素的影响。在这个项目期结束时,我们将更好地了解
关节环境--尤其是炎症信号--如何影响软骨的最终成功
使用异种祖细胞群体的再生策略。
英文摘要
Current standards of care for cartilage injuries cannot reliably provide sustained clinical improvement, so
there is much interest in the development of alternative, biological approaches towards repair/regeneration.
Regenerative medicine approaches typically involve the recruitment or transplantation of endogenous
mesenchymal progenitor cells (MFCs) to the defect site. Under controlled conditions, these cells have the
potential to proliferate, differentiate along the relevant musculoskeletal lineage and regenerate damaged
tissue matrix. However, the intra-articular environment can be hostile to chondrogenesis; specifically,
inflammation within the injured joint can inhibit tissue regeneration. Joint inflammation is mediated locally by
cytokines such as interleukin-1 and tumor necrosis factor-a. Although proinflammatory cytokines play an
important role in the pathogenesis of osteoarthritis, little is known about how they affect cartilage repair
strategies involving MFCs. The central hypothesis shaping this project is that inflammation secondary to joint
trauma or subsequent surgical intervention can inhibit the regenerative activity of MFCs within the cartilage
defect, thus limiting repair. During the mentored phase, a toolset of reporter constructs were developed for
monitoring the state of human MFC differentiation, using these constructs to non-invasively track
inflammatory and chondrogenic activity within an immunocompromised rat model of cartilage injury. Upon
transition to the independent phase of the project, tools developed during the mentored phase will help
characterize the proinflammatory environment resulting from surgically-induced joint trauma, identifying
factors that impair chondrogenesis and defect repair. Both immunologically-competent and -incompetent
animal models of joint injury will be used to determine the ability of MFCs to repair/regenerate cartilage when
protected from the identified factors. At the end of this project period, we will have a better understanding of
how the joint environment - particularly inflammatory signaling - impacts the ultimate success of cartilage
regeneration strategies using heterogeneous progenitor cell populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extracellular vesicles as therapeutic vehicles for chondroprotection
-
批准号:10117408
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2019
-
负责人:Ryan Michael Porter
-
依托单位:
Extracellular vesicles as therapeutic vehicles for chondroprotection
-
批准号:10357781
-
项目类别:
-
资助金额:$31.05万
-
财政年份:2018
-
负责人:Ryan Michael Porter
-
依托单位:
Extracellular vesicles as therapeutic vehicles for chondroprotection
-
批准号:10268960
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2018
-
负责人:Ryan Michael Porter
-
依托单位:
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo
-
批准号:9592522
-
项目类别:
-
资助金额:$1.56万
-
财政年份:2017
-
负责人:Ryan Michael Porter
-
依托单位:
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo
-
批准号:9217577
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2016
-
负责人:Ryan Michael Porter
-
依托单位:
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo
-
批准号:9015521
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2016
-
负责人:Ryan Michael Porter
-
依托单位:
Facilitating cartilage regeneration by heterogeneous progenitor cells
-
批准号:8330976
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Ryan Michael Porter
-
依托单位:
Facilitating cartilage regeneration by heterogeneous progenitor cells
-
批准号:8530951
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2009
-
负责人:Ryan Michael Porter
-
依托单位:
Facilitating cartilage regeneration by heterogeneous progenitor cells
-
批准号:7643619
-
项目类别:
-
资助金额:$8.56万
-
财政年份:2009
-
负责人:Ryan Michael Porter
-
依托单位:
Gene-activated Bone Marrow Plugs for Cartilage Repair
-
批准号:7159066
-
项目类别:
-
资助金额:$4.4万
-
财政年份:2006
-
负责人:Ryan Michael Porter
-
依托单位:
Gene-activated Bone Marrow Plugs for Cartilage Repair
-
批准号:7707313
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2006
-
负责人:Ryan Michael Porter
-
依托单位:
Gene-activated Bone Marrow Plugs for Cartilage Repair
-
批准号:7294944
-
项目类别:
-
资助金额:$2.74万
-
财政年份:2006
-
负责人:Ryan Michael Porter
-
依托单位:
海外基金